Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-022491
Filing Date
2020-02-18
Accepted
2020-02-18 17:16:06
Documents
2
Period of Report
2020-02-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm209314-1_8ka.htm 8-K/A 17870
2 EXHIBIT 16.1 tm209314-1_ex161.htm EX-16.1 6262
  Complete submission text file 0001104659-20-022491.txt   25520
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-35963 | Film No.: 20626390
SIC: 2834 Pharmaceutical Preparations